User profiles for T. Ueda

Takuya Ueda

- Verified email at aoni.waseda.jp - Cited by 17180

Takashi Ueda

- Verified email at nibb.ac.jp - Cited by 15668

GaN-on-Si power technology: Devices and applications

…, A Lidow, C lin Tsai, T Ueda… - … on Electron Devices, 2017 - ieeexplore.ieee.org
In this paper, we present a comprehensive review and discussion of the state-of-the-art device
technology and application development of GaN-on-Si power electronics. Several device …

GaN on Si technologies for power switching devices

…, T Ueda, T Tanaka, D Ueda - IEEE Transactions on …, 2013 - ieeexplore.ieee.org
Ueda, “Recent advances in GaN transistors for future emerging applications,” Phys. Stat. …
Uemoto, T. Tanaka, and D. Ueda, “GaN transistors for power switching and millimeter-wave …

Guidelines and recommendations for perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the writing group on perfusion …

RE Latchaw, H Yonas, GJ Hunter, WTC Yuh, T Ueda… - Stroke, 2003 - Am Heart Assoc
… With thrombolytic treatment: Based on 42 lesions in 30 patients, Ueda et al 22 reported
that the rCBF threshold for reversibility of the ischemic process with intra-arterial thrombolysis …

[HTML][HTML] Nivolumab versus everolimus in advanced renal-cell carcinoma

…, P Bono, J Wagstaff, TC Gauler, T Ueda… - … England Journal of …, 2015 - Mass Medical Soc
… is a fully human IgG4 programmed death 1 (PD-1) immune checkpoint inhibitor antibody
that selectively blocks the interaction between PD-1, which is expressed on activated T cells, …

Gate injection transistor (GIT)—A normally-off AlGaN/GaN power transistor using conductivity modulation

…, T Ueda, T Tanaka, D Ueda - … on Electron Devices, 2007 - ieeexplore.ieee.org
We have developed a normally-off GaN-based transistor using conductivity modulation,
which we call a gate injection transistor (GIT). This new device principle utilizes hole-injection …

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck …

…, K Tanaka, T Ueda, H Yamaguchi, T Yamazaki… - The Lancet, 2019 - thelancet.com
Background Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC),
with programmed cell death ligand 1 (PD-L1) expression associated with improved …

Cell-free translation reconstituted with purified components

…, T Suzuki, T Yokogawa, K Nishikawa, T Ueda - Nature …, 2001 - nature.com
We have developed a protein-synthesizing system reconstituted from recombinant tagged
protein factors purified to homogeneity. The system was able to produce protein at a rate of …

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

T Ueda, S Volinia, H Okumura, M Shimizu… - The lancet …, 2010 - thelancet.com
… After filtration of microRNAs, we used the paired t test (level of significance, p<0·01) to
independently analyse pairs of non-tumour mucosa and cancer samples from groups 1 and 2. We …

[PDF][PDF] Insights into land plant evolution garnered from the Marchantia polymorpha genome

…, D Takezawa, H Tomogane, M Tsuzuki, T Ueda… - Cell, 2017 - cell.com
The evolution of land flora transformed the terrestrial environment. Land plants evolved from
an ancestral charophycean alga from which they inherited developmental, biochemical, and …

Preparation of phospholipid polymers and their properties as polymer hydrogel membranes

K Ishihara, T Ueda, N Nakabayashi - Polymer Journal, 1990 - nature.com
… from the linear part of the permeation profile, they were 1.73 x 10 cm“ s T * at 30C, 2.10 y
10 º cmº s T * at 40C, and 2.60 x 10 Tº cmº s T * at 50C. The permeation coefficient increased …